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INTRODUCTION 
 
Acute coronary syndrome 
The acute coronary syndrome comprises three 
different entities, ST elevation myocardial 
infarction (STEMI), Non ST elevation 
myocardial infarction (NSTEMI) and unstable 
angina (UAP). These share a common cause, 
namely impaired supply of oxygenated blood 
to the myocardium, which is again caused by 
atherosclerotic or thrombotic narrowing or 
occlusion in the coronary arteries. This in turn 
may lead to ischemic symptoms, impaired 
myocardial function and myocardial necrosis. 
Patients with acute myocardial infarction are 
upon first medical contact dichotomized 
according to their presenting electrocardiogram 
(ECG). Patients with STEMI are perceived to 
have total occlusion of an epicardial coronary 
artery and a large area of myocardium at risk 
of necrosis. Prognosis after myocardial 
infarction (MI) is closely linked to the size of 
the infarct, and to residual left ventricular (LV) 
function.1 Hence, treatment is aimed at limiting 
infarct size and preserving LV function by 
restoration of flow, either medically by 
thrombolysis or mechanically by percutaneous 
coronary intervention (PCI). Patients with 
NSTEMI are rarely treated with acute 
reperfusion. They are stabilized medically, and 
those with high risk features are recommended 
to undergo coronary angiography within 48-72 
hours, with subsequent revascularization if 
indicated.   
The ECG is insensitive towards detection of 
acute coronary occlusion and substantial 
infarction.2,3 Registry data have revealed that 
the culprit lesion is occluded in 24% of 
patients with NSTEMI, and that these patients 
suffer worse outcomes.4 There is also a large 
overlap in final infarct size between STEMI 
and NSTEMI patients.5 Therefore, there is a 
need for methods to rapidly identify patients 
with acute occlusion and/or substantial 
infarction, in the absence of ST-segment 
elevation.  
Detection of myocardial ischemia by 
echocardiography. 
This whole thesis is based on detection and 
quantification of ischemia and necrosis 
through detection and quantification of 
changes in myocardial systolic function. The 
close relationship between myocardial systolic 
function and ischemia was first elegantly 
demonstrated by Tennant and Wiggers in 
1935.6 Acute ischemia induces sequential 
changes in regional myocardial function; 
initially reduced systolic contraction and later 
systolic distention. These changes occur and 
may be detected within few seconds after 
abrupt cessation of blood supply.7 
Transthoracic echocardiography is today the 
most widely used diagnostic tool for evaluation 
of global and regional myocardial systolic 
function. Several other imaging modalities 
have been developed for evaluation of 
myocardial function. However, no other 
modality yield the unique combination of 
detailed real-time information, high spatial and 
temporal resolution and comprehensive 
information on cardiac structure and function, 
in addition to being cheap, non-invasive and 
rapidly available. If assessment of myocardial 
function is to be implemented in initial 
evaluation of patients with suspected MI, the 
above mentioned properties give 
echocardiography several advantages 
compared to other imaging modalities. 
Echocardiographic parameters of 
systolic function 
Several echocardiographic parameters are in 
use for quantification of myocardial systolic 
function. The most widely used is the left 
ventricular ejection fraction (LVEF),8,9 which 
represents the stroke volume as a fraction of 
the end diastolic volume: 
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LVEF is widely validated as a prognostic 
indicator after acute MI,10 but has several 
disadvantages, including high interobserver 
variability.11 In addition, it is a measure of 
global and not regional function. 
Compensatory increased contractions in non-
ischemic regions may result in only small 
changes in LVEF, and masque large areas with 
impaired function. Wall motion score (WMS) 
is another widely used parameter of LV 
systolic function.12 It is based on visual 
assessment of systolic endocardial excursion 
on an ordinal scale, most often in a 16 
segments model.13 Segments are scored as 1= 
normal, 2=hypokinetic, 3=akinetic and 
4=dyskinetic. Wall motion score index 
(WMSI) is calculated as the mean of analyzed 
segments. Compared to LVEF it is less 
affected by regional hyperkinesia, but is 
limited by dependence of the experience and 
the subjective interpretation of the observer.  
Tissue Doppler provides information about 
velocities in tissue relative to a transmitter. 
Through the Doppler equation  
 
velocity (v) is calculated based on the shift in 
frequency between transmitted and received 
frequency ( . Velocity of sound in tissue (c) 
and the transmitted frequency ( ) are known 
constants. The measurement is angle 
dependant, but misalignment of up to 25  will 
only underestimate true velocity by up to 
approximately 10%.  Myocardial velocities are 
obtained from pulsed Doppler recordings or 
color coded 2D images. Applied on images 
from the apical view, these measurements 
provide quantitative information on myocardial 
longitudinal function. Decreased systolic 
velocity has been demonstrated in ischemic 
myocardium.14 Displacement can be calculated 
from the time integral of velocity, providing 
information on translation of the myocardial 
region. Both velocity and displacement data 
are hampered by tethering; the measurements 
are affected by velocity and displacement in 
neighboring regions. Together with the 
emergence of strain echocardiography, this 
may be why velocity based assessment of 
myocardial function has not reached 
widespread clinical use, despite being available 
for more than a decade. 
Strain echocardiography 
Strain is a dimensionless measure of the 
deformation that occurs upon application of 
stress. It represents the fractional or percentage 
change between the unstressed and stressed 
dimension. Theoretically, it can be calculated 
along any given axis. Throughout systole, the 
myocardium shortens along a longitudinal axis, 
thickens along a radial axis and shortens along 
a circumferential axis. These deformations are 
caused by generation of active force, through 
myocardial muscle fiber contraction. Hence, 
quantification of strain along any of these axes 
represents a measure of deformation and 
consequently contractile function in the 
assessed region.   
 
 
 
 
Strain Doppler echocardiography 
To overcome the tethering problems inherent 
in velocity measurements, strain Doppler 
echocardiography was developed. The basis of 
Doppler-based strain is the velocity gradient; if 
two points measured from a set distance from a 
transmitter have different velocities, the 
difference in velocity represents the instant rate 
of deformation between the two points, the 
strain rate. Strain is then obtained through the 
time integral of strain rate. During the last 
decade, extensive research has been performed 
on myocardial systolic function using both 
strain and strain rate,15 in a variety of clinical 
and experimental settings. Results have been 
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promising, but clinical use is still scarce. Even 
though the tethering issues were largely 
overcome by strain Doppler, other issues have 
limited clinical application; since 
measurements are based on a velocity gradient, 
the signal is noisy and separation between 
signal and artifact can be difficult. The angle 
dependency is much greater for strain than 
velocity,16 making careful alignment of the 
axes very important.  Post processing is time 
consuming, and requires a certain level of 
experience and expertise in order to make the 
correct interpretation.  
Speckle tracking echocardiography 
A novel approach to strain echocardiography 
has been developed called “Speckle tracking 
Echocardiography” (STE). This modality uses 
conventional 2D cine loop images for 
calculation of strain. Instead of calculating 
strain from velocity, strain is calculated 
directly from tracking consistent pixel patterns 
(speckles) from frame to frame. Speckles can 
be tracked in all directions, eliminating the 
angle dependency in Doppler strain. This 
implies that deformation can also be assessed 
along circumferential and radial axes, in 
addition to longitudinal. However, since linear 
resolution parallel to the ultrasound beam is 
limited only by the ultrasound wavelength 
(typically 0.5-1mm) while resolution 
perpendicular to the beam is limited by the 
ultrasound beam with, longitudinal strain has a 
theoretical advantage. STE has been validated 
against sonomicrometry and tagged magnetic 
resonance imaging (MRI), both clinically and 
experimentally, under ischemia and different 
loading conditions.17 Compared to Doppler 
strain, the signal is less noisy, post processing 
can be performed much more rapidly, and semi 
automatic algorithms have also been 
developed. The latter may facilitate clinical 
utilization. STE is based on 2D images, and the 
signal-to-noise ratio is dependent on image 
quality. Reverberations, drop-outs and poor 
image quality may represent sources of error. 
Automatic algorithms to accept or discard 
analyzed segments are developed and refined, 
but should not replace visual confirmation of 
tracking. Feasibility and reproducibility has 
proven excellent.18 
Summary 
There is a close relationship between 
myocardial perfusion and myocardial systolic 
function. In this thesis, we wanted to assess 
whether impaired perfusion could be identified 
and quantified by echocardiographic estimates 
of myocardial systolic function. This may 
solve a clinical problem, namely accurately 
identifying NSTE-ACS patients at high risk of 
adverse events. Above, several different 
methods to estimate myocardial systolic 
function are summarized. Paradoxically, 
despite substantial technological development 
and improvements in image quality, the 
echocardiographic parameters most used today 
were developed decades ago. The primary 
objective of our studies was to show that 
echocardiography, irrespective of method, is a 
feasible tool for risk stratification of patients 
with NSTE-ACS. Without prejudice, new and 
older modalities were compared with respect to 
their ability to detect and quantify myocardial 
ischemia and/or necrosis. 
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AIMS OF THE THESIS 
 
General Aims 
The general objective of this thesis was to determine the value of echocardiography for stratification of 
patients with non ST-segments elevation acute coronary syndrome (NSTE-ACS). Specifically, we 
sought to assess whether echocardiographic estimates of systolic function could be used to identify 
patients at high risk.  
Specific aims 
 
I  To investigate in a clinical study the ability to identify patients with acute coronary occlusion 
 by echocardiographic parameters of global and regional systolic function. 
 
II  To investigate the relationship between echocardiographic parameters of myocardial systolic 
 function prior to revascularization and final infarct size, as measured by MRI. Specifically, we 
assessed the ability to identify patients with substantial infarction.  
 
III  To investigate the ability of post systolic shortening (PSS) to predict recovery of systolic 
 function in patients with NSTEMI and impaired regional systolic function at baseline, and to  
 compare the added value of PSS compared to angiographic and other parameters.  
 
IV  To investigate temporal changes in myocardial systolic function between hospital admittance 
 and subsequent coronary angiography 1-2 days later.  
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MATERIAL 
Study population (paper I-III) 
The studies were conducted on Oslo University 
Hospital (OUS), Rikshospitalet, which is a 
tertiary coronary care center providing 
coronary angiography and intervention 
services. Consecutive patients from referring 
hospitals were screened for enrollment upon 
arrival. Between May 2007 and June 2008, 150 
patients (40 women), 58±9 (mean±SD) years 
of age were enrolled. Inclusion criteria were 
age ≥ 18 years, a clinical diagnosis of NSTE-
ACS and planned coronary angiography within 
3 days of index admission. Time from index 
hospital admission to coronary angiography 
was 2.2±0.7 (range 1-3) days. Major exclusion 
criteria were: prior MI, evidence of STEMI 
(ST-elevation > 0.1mV [0.2mV in precordial 
leads V1-V 3]) in two or more contiguous leads 
on any ECG during index admission, bundle 
branch block with QRS > 120ms, severe 
valvular disease, previous heart surgery, 
extensive comorbidity with short life 
expectancy, atrial fibrillation with heart rate > 
100 or any condition interfering with the 
patient’s ability to comply.  
A total of 756 patients were screened for 
inclusion, of whom 150 (20%) were included. 
Patient characteristics are summarized in table 
1.  The major reasons for exclusion were; 
previous MI (n=212), delayed referral (n=193), 
previous CABG (n=193), comorbidity (n=30), 
and wide QRS (n=22). Only 4 patients refused 
participation, and no patients were excluded 
due to poor echocardiographic image quality.  
Patients paper I 
In paper I, the entire 150 patients enrolled were 
examined. Of these, 124 (83%) were referred 
with a diagnosis of NSTEMI based on elevated 
troponin I or T, the remaining 26 (17%) had 
UAP. All patients underwent coronary 
angiography the same day they arrived at OUS. 
Echocardiography was performed immediately 
prior to coronary angiography. The latter was 
important to ensure that the echocardiogram 
reflected status prior to revascularization.  
Patients paper II 
In paper II, the primary objective was to 
determine the relationship between myocardial 
systolic function and final infarct size in 
patients with NSTEMI. From the total 
population, 61 patients aged 57±9 years (13 
women) underwent examination with late 
enhancement magnetic resonance imaging to 
determine final infarct size, 9±3 months after 
inclusion. All patients had NSTEMI evident by 
elevated troponin I or T at baseline.  
Patients paper III 
In paper III, the objective was to determine the 
ability of PSS to predict improvement in 
systolic function among patients with NSTEMI 
and impaired regional systolic function at 
baseline. From the total population of 150 
patients, 35 patients aged 56.3±10 years (5 
women) had a combination of NSTEMI, an 
identified culprit lesion, impaired regional 
systolic function at baseline, successful 
complete revascularization and a follow up 
echocardiogram 9±3 months after inclusion. 
Impaired systolic function at baseline was 
defined as at least one segment with WMS ≥ 2 
within the culprit region.  
Study population paper IV 
This study was conducted at Sykehuset 
Sørlandet, Arendal, which is a local hospital 
with invasive cardiologic services. Inclusion 
criteria were: 1) Acute anginal pain lasting for 
at least 10 minutes and clinically classified as 
unstable angina pectoris or NSTEMI; 2) A 
history of chest pain less than 3 days; 3) 
indication for coronary angiography according 
to current guidelines. Exclusion criteria were 
similar to study I-III, except patients with 
previous myocardial infarction were not 
excluded.  102 patients were included, and 
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retrospectively grouped according to discharge 
diagnosis as having NSTEMI, UAP or non 
coronary chest pain. 
 
 
Patients n=150  
Age (years) 57.7 ± 9.0  
BMI (kg/m
2
) 27 ± 3.6  
   
Risk Factors n % 
   Male gender 110 73 % 
   Current smoker 55 37 % 
   Hypercholesterolaemia 39 26 % 
   Hypertension 60 40 % 
   Diabetes Mellitus 12 8 % 
   History of CAD 8 5 % 
   Troponin positive 123 82 % 
   
Medication   
   Aspirin 149 99 % 
   Clopidogrel 146 97 % 
   LMWH 144 96 % 
   β-blocker 122 81 % 
   Statin 135 91 % 
   Warfarin 1 1% 
   ACE/ARB 40 27 % 
   Gp2b3a inh.   
Table 1. Patient characteristics 
BMI indicates body mass index; CAD, coronary artery 
disease; LMWH, low molecular weight heparin; ACE, 
angiotensin converting enzyme, ARB, Angiotensin receptor 
blocker; GpIIbIIIa, glycoprotein IIbIIIa. 
14 
 
METHODS 
 
Echocardiography 
Echocardiography was performed in the left 
lateral decubital position, using a Vivid 7 
scanner, equipped with a 2.5 MHz probe (GE 
Vingmed, Horten, Norway). In short axis view, 
three consecutive cycles were obtained at the 
basal-, mid ventricular- and apical level. From 
the apical view, three consecutive cycles were 
obtained in four chamber-, two chamber- and 
long axis view. Frame rate ranged from 69±12 
(Study III) to 74±9 (study IV) frames/s. In 
study I-III, echocardiography was performed 
immediately prior to coronary angiography, 
and at follow up 9±3 months later. In study IV, 
echocardiography was performed at 
admittance, immediately prior to coronary 
angiography, and at follow up 99±20 days 
later. LVEF was calculated using the modified 
Simpson’s rule from two- and four chamber 
images. WMSI was calculated in a 16 
segments model.13 As all echocardiographic 
methods in this thesis rely on the quality of 2D 
grayscale images, great care was taken to 
acquire high quality images. Mitral inflow 
velocity (E) was recorded by pulsed Doppler 
with the sample volume placed between the 
leaflet tips. Early diastolic mitral annular 
velocity (e’) was recorded by tissue Doppler 
using color mode, and calculated by averaging 
values from septum and the lateral wall in four 
chamber view. The E/e’ ratio correlates to LV 
filling pressure,19 and is reported in study IV. 
All images were digitally stored, and later 
analyzed off-line in a blinded fashion.  
Strain analysis 
In this thesis, speckle tracking was used to 
estimate strain. This relatively new algorithm 
calculates segmental deformation by tracking 
acoustic markers from within the myocardium 
on a frame-to-frame basis. A region of interest 
(ROI) was manually drawn, and adjusted if 
tracking was not optimal. Quality of tracking 
was assessed both by the automatic algorithm 
within the software, as well as visually. 
Segments with suboptimal tracking were 
discarded. Filters for temporal and spatial 
smoothing were kept in default position, to 
avoid introducing potential confounding. In 
papers I-III, peak negative systolic strain was 
used as a measure of segmental systolic 
function in the longitudinal and circumferential 
directions, peak positive systolic strain in the 
radial direction. In paper IV, peak systolic 
strain was used, representing the point on the 
strain curve that has the largest absolute value 
within systole. The software output generates 
strain values in an 18 segments model, which 
was converted to 16 segments by averaging 
strain values from adjacent segments in four 
chamber- and long axis view. Global 
longitudinal strain (GLS), global 
circumferential strain (GCS) and global radial 
strain (GRS) were obtained by averaging 
values from analyzed segments.  
In paper I a new term; the “functional risk 
area” was introduced. Previously, 
experimental studies have demonstrated an 
excellent correlation between the ischemic risk 
area and the area of regional systolic 
dysfunction.21,22 We therefore assessed the size 
of the area with impaired systolic function, 
defined as the number of adjacent segments 
with systolic dysfunction. Systolic dysfunction 
was defined separately using WMS and strain, 
and segments with WMS ≥ 2 or segmental 
longitudinal strain ≥ -14% were defined as 
dysfunctional. 
Torsion has been introduced as a measure of 
global LV systolic function,20 and was used in 
paper II. It was measured by speckle tracking, 
and calculated as the difference in rotation 
between the basal and apical planes.  
In paper III, PSS was used as a predictor of 
recovery of systolic function. PSS was 
measured in long axis view by STE, and 
defined as the segmental shortening in diastole 
beyond minimum systolic segment length, as 
percentage of end diastolic segment length; i.e. 
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peak negative strain in diastole minus peak 
negative strain in systole (figure 1). If 
maximum segmental shortening was within 
systole, PSS was set to zero. Hence, PSS could 
only take negative values. Duration of systole 
was defined in apical long axis view as the 
time from peak R in the ECG to the first frame 
where the aortic valve was closed.  
 
  
In paper III and IV, strain values from the 
culprit territory, based on a standardized 
division of the LV into three vascular beds 
(LAD, LCx and RCA), were used in 
accordance with established 
recommendations.13 
Coronary angiography 
Coronary angiography was performed on 
clinical indication by standard (Judkins) 
technique,23 using digital imaging acquisition 
and storage. Revascularization was not part of 
study protocol, and PCI was performed at the 
discretion of the operator. Cine loops in 
multiple angles were stored, and all analyses 
were performed off-line, blinded to the results 
of the echocardiographic analyses. TIMI-flow 
was noted, and acute occlusion was defined as 
TIMI-flow 0 or 1 in the infarct related artery 
(IRA). Acute occlusions were differentiated 
from chronic total occlusions by angiographic 
appearance (thrombus, collaterals, 
calcification), and by the ease with which a 
guide wire could cross the lesion. Occlusive 
lesions were classified as being either in the 
proximal or mid part of a major coronary 
artery, as opposed to in a distal part or branch 
(paper I). The number of diseased vessels 
(diameter stenosis ≥50%) was noted, and 
patients with significant stenosis were 
dichotomized as having single- or multi vessel 
disease.  
Magnetic resonance imaging (MRI) 
Contrast enhanced MRI (CE-MRI) has a high 
spatial resolution, and is considered the gold 
standard for assessment of infarct size.24 For 
clinical use, it is limited by cost, availability 
and time consumption. In paper II, CE-MRI 
was used as the reference method to assess 
infarct size at follow up 9±3 months after 
inclusion. An example is demonstrated in 
figure 2.  
 
 
Figure 2. Short axis MRI images from basis (upper left) 
to apex (lower right), demonstrating late enhancement in 
the lateral wall. 
 
The delay between the infarct and assessment 
of final infarct size allows LV remodeling and 
shrinkage of infarct size to complete.25 
Imaging was performed on 61 patients, using a 
1.5-T units (Magnetom Sonata, Siemens, 
Erlangen, Germany) on 29 patients, and a 3-T 
Figure 1 PSS was defined as segmental 
shortening in diastole beyond minimum 
systolic segment length.  
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units (Philips Medical Systems, Best, The 
Netherlands) on 32 patients. Late enhancement 
images were obtained 10-20 minutes after 
intravenous injection of 0.1 to 0.2 mmol/kg 
gadopentetate dimeglumine (Magnevist, 
Schering, Berlin, Germany) in multiple short-
axis slices covering the entire LV. Typical 
image parameters were slice thickness 8mm, 
gap 2mm, inversion time 270ms. On each short 
axis image, total myocardial area as well as 
area of infarcted myocardium was manually 
drawn (PACS, Sectra, Sweden). Final infarct 
size was calculated as infarct volume as  
percentage of total myocardial volume. 
Segmental transmurality was calculated in a 16 
segments LV model as infarct volume divided 
by myocardial volume pr. segment, and 
segments with ≥ 50% contrast enhancement 
were judged transmurally infarcted.26  Both 
short and long term mortality have been 
demonstrated to be increased in patients with 
infarct size ≥12%.
1,27 Therefore, patients were 
dichotomized by infarct size using 12% as cut 
off.  
 
Statistical methods 
Data were presented as n (percentage) for 
categorical variables, mean ± standard 
deviation (SD) for continuous variables with 
normal distribution, and median (inter quartile 
range) for continuous variables with skewed 
distributions. Infarct size and WMSI are 
typical examples of variables with skewed 
distributions. Distributions were assessed by 
graphically by histograms and Q-Q plots. 
Categorical variables were analyzed using Chi-
square test or Fishers Exact test. For 
continuous variables, differences between 
groups were analyzed using student t test (two 
samples or paired samples), one way analysis 
of variance (ANOVA), Mann-Whitney U test 
or Kruskal-Wallis test as appropriate. In paper 
II, the relationship between parameters of 
systolic function and infarct size was assessed 
by univariate linear regression (least squares). 
Similarly, in paper III, multivariate linear 
regression was used to determine predictors of 
recovery of systolic function. Logistic 
regression was used to identify predictors of 
acute coronary occlusion (paper I) and infarct 
size ≥ 12% (paper II). Inter- and intra observer 
variability was calculated by intra class 
correlation coefficient in randomly selected 
patients. 
Receiver operator characteristic (ROC) 
analyses were used in paper I-III, primarily to 
assess discrimination, and also to determine 
optimal cut-off levels to maximize sensitivity 
and specificity. An example is demonstrated in 
figure 3. The area under the curve (AUC) is a 
parameter of discriminating ability. AUC with 
95% confidence interval are reported, and 
compared according to the method described 
by Hanley and McNeil,28 using dedicated 
software (MedCalc Software v. 10.3.1.0, 
Mariakerke, Belgium).  All other statistical 
analyses were performed on SPSS v. 13 (SPSS 
Inc. Chicago, IL). 
 
Figure 3. ROC analysis set to identify infarct 
size ≥ 12% of to LV myocardial volume 
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SUMMARY OF RESULTS 
Paper I 
In this study, we hypothesized that NSTE-ACS 
patients with acute occlusion of the infarct 
related artery (IRA) have impaired systolic 
global LV function, and a larger area of 
myocardium with impaired systolic function, 
compared to patients with a patent IRA.  
Acute coronary occlusion was found in 33 
patients (22%). All the assessed 
echocardiographic parameters of LV systolic 
function were significantly impaired in patients 
with acute occlusion compared to patients with 
a patent IRA: LVEF; 54.9±9.6 vs. 59.1 ±7.6%, 
p=0.02, WMSI; 1.16 (1.03 - 1.36) vs. 1.00 
(1.00 - 1.13), p<0.001, global longitudinal 
strain; -15.0±2.4 vs. -17.4±2.5%, p<0.001. In 
addition, the area with impaired systolic 
function was increased: risk area by WMS; 
median 3 (IQR 0.5 - 4) vs. 0 (IQR 0 - 2) 
segments, p<0.001, risk area by strain; median 
7 (IQR 4.5 – 9) vs. 2 (IQR 0 - 5) segments, 
p<0.001. No significant differences were found 
in clinical or electrocardiographic parameters. 
Troponin T was significantly increased in 
patients with acute occlusion (1.0±1.1 vs. 
0.3±0.7 μg/l, p<0.01). The latter is likely to 
reflect a larger amount of myocardial necrosis.  
ROC analysis demonstrated that the functional 
risk area estimated as the number of adjacent 
segments with longitudinal strain ≥ -14% had 
the best ability to identify patients with acute 
occlusion (AUC 0.81 [95% confidence interval 
0.74 – 0.88], p<0.001). With cut off at ≥ 4 
segments, we find sensitivity 85% and 
specificity 70%.  
Paper II 
In this study, we assessed the ability of strain 
echocardiography and established indices of 
LV systolic function to predict final infarct 
size. Previously, infarct size ≥ 12% has been 
associated with increased mortality, and we 
specifically assessed the ability to identify 
individual patients with infarct size ≥12%.  
Infarct size followed a right skewed 
distribution, with median 5.4% and IQR 1.7 – 
11.4%. 13 patients (21%) had infarct size 
≥12%. All echocardiographic parameters of 
LV systolic function demonstrated significant 
correlation to final infarct size. WMSI (r=0.74, 
p<0.001) and GLS (r=0.68, p<0.001) 
demonstrated the strongest correlations.  
The ability to identify patients with infarct size 
≥ 12% was excellent for GLS (AUC 0.95 [95% 
CI 0.86 – 0.99]) and WMSI (AUC 0.93 [[95% 
CI 0.83 – 0.98]). Both were superior to LVEF, 
GCS, GRS and torsion. No clinical or 
electrocardiographic criteria were able to 
identify patients with infarct size ≥ 12%. 
Logistic regression demonstrated that 
combining echocardiographic parameters did 
not increase discriminating power. At follow 
up, a persistent impairment of LV systolic 
function was found in patients with infarct size 
≥12% compared to those with smaller infarcts 
(GLS -14.1±2.0% vs. -17.5±2.2%, p<0.001). 
Paper III 
PSS has previously been associated with viable 
myocardium. The association between PSS and 
change in systolic function between baseline 
(before revascularization) and follow up 9±3 
months after successful revascularization was 
assessed in this study. Change in systolic 
function was calculated as difference in 
longitudinal strain values at baseline and 
follow up (ΔStrain).  
PSS was present in 32 patients (91%) at 
baseline, mean -1.9±1.4%. In the myocardial 
territory supplied by the infarct related artery, 
mean ΔStrain was -3.3±2.9 %. Improved 
systolic function was found 30 patients (86%).  
Systolic function at baseline was found to be a 
confounder of improvement , as a larger 
absolute ΔStrain was found in patients with 
poor function at baseline (correlation between 
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ΔStrain and baseline function; r=-0.58, 
p<0.001). After adjustment for the 
confounding effect of baseline systolic 
function, PSS and angiographic severity of the 
culprit lesion were significant predictors of 
ΔStrain. In a multivariate regression model, 
PSS had the strongest prognostic power (PSS 
standardized β = 0.38, angiographic severity 
standardized β = 0.33).  
Paper IV 
Temporal changes in patients with suspected 
NSTE-ACS awaiting coronary angiography 
have not previously been determined.  
In patients with NSTEMI, we found a small 
but significant deterioration in longitudinal 
global strain from -16.1±2.6% at admittance to 
-15.0±2.6% before coronary angiography 
(p<0.001). This was due to deterioration in 
longitudinal strain in the territory supplied by 
the infarct related artery from -14.2±4.2% to 
-12.0±4.1% (p<0.001), whereas strain in 
remote area was unchanged. This deterioration 
was most pronounced in patients with total 
occlusion of the infarct related artery at 
coronary angiography. No change was 
observed in LVEF or global circumferential 
strain. No change in LV systolic function was 
observed in patients with UAP or non coronary 
chest pain.  
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DISCUSSION 
Study design and protocol 
This study was designed, and the protocol was 
written, to assess whether echocardiography 
may be a useful tool for stratification of 
patients with NSTE-ACS, with respect to 
extent of coronary pathology and myocardial 
necrosis. For the findings in clinical studies 
like these to be applicable to a general 
population, some conditions concerning patient 
selection, choice and use of methods and end 
points must be fulfilled. These will be 
discussed below. 
Patient selection 
All clinical studies will have inclusion and 
exclusion criteria. Still, it is important that the 
studied population as closely as possible 
resembles patients in an unselected population. 
In our studies I-III, assessment was limited to 
patients who were referred for coronary 
angiography, as the studies were performed at 
the referral centre. This of course may 
introduce a selection bias. Nevertheless, we 
sought to identify patients with acute coronary 
occlusion or substantial MI, who may benefit 
from acute reperfusion therapy. Patients with 
MI who are not referred for coronary 
angiography following MI are also unlikely to 
be candidates for acute revascularization. Still, 
we may have missed some of the most 
seriously ill patients, who may have died or 
become too unstable for transport while 
awaiting coronary angiography, thus 
introducing a bias towards patients with less 
serious disease. On the other hand, some 
patients with suspected or confirmed NSTE-
ACS may have been stabilized medically, and 
never been referred to coronary angiography. 
These patients may suffer from less serious 
disease, introducing a bias towards more 
seriously ill patients in the studied population. 
By including study IV in this thesis, we are 
able to provide data from the initial period 
during which patients are stabilized. In studies 
I-III, findings are limited to patients without 
previous MI. As it is difficult to differentiate 
acute from chronic MI by echocardiographic 
estimates of LV systolic function, this 
selection was necessary.  
Patients with a delay of more than three days 
before arrival were excluded from our studies. 
The main reason for this is that we wanted to 
study a population treated according to current 
guidelines, which recommend a delay of 72 
hours at most.29 Good compliance to guidelines 
in the studied population is confirmed by the 
large proportion of patients on dual platelet 
inhibition, beta blockers and LMWH. The 
number of patient excluded due to delayed 
referral was relatively large, (n=193). As 
patients with less serious disease may be more 
likely to wait longer, this may also introduce a 
bias towards patients with more serious 
disease.  
A large scale registry study including more 
than 30,000 NSTEMI patients, also excluding 
those with previous MI or CABG, found a 
prevalence of an occluded IRA of 24%.4 This 
is virtually identical to our population, where 
an occluded IRA was found in 33 out of 150 
patients (22%), and may indicate that the 
frequency of serious disease in our population 
does not deviate substantially from what would 
be expected in an unselected population.  
Our population is relatively young (mean age 
58 years). The reason for this is probably 
found in the exclusion criteria. Patients 
excluded due to previous MI (mean age 66 
years), delayed referral (mean age 65 years) 
and previous CABG (mean age 69 years) were 
all significantly older (all p<0.01). This, 
however, does not imply that our findings 
apply only to younger patients. In all studies, 
we tested whether age was a confounder or 
effect modifier, and did not find any evidence 
of such. In addition, the age of the patients 
studied ranged from 37 to 79 years, thus 
representing a broad age spectrum.  
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Selection and use of methods 
Another important issue concerning whether 
findings are applicable to a broader population, 
is the choice and use of methods. Post-hoc 
application of numerous tests, calculation of 
indexes and reporting positive findings will 
result in over fitting of statistical models, and 
poor reproducibility of results. To avoid this, it 
is important that analyses are predefined, and 
that findings are consistent using different 
methods. In our studies, all parameters used to 
estimate LV function (volumes, LVEF, global 
and regional systolic strain, WMSI, and PSS) 
were used according to study protocol. The 
echocardiographic methods have differences, 
which will be discussed in detail below, but 
findings are consistent. For example, acute 
coronary occlusion results in short and long 
term impairment of LV systolic function, 
measured by either strain echocardiography, 
LVEF or WMSI. Likewise, patients with 
infarct size ≥12% have impaired LV systolic 
function compared to patients with smaller 
infarcts, regardless of method.  
One important caveat that is difficult to avoid 
concerning the general applicability of 
findings, is the quality of the data used in the 
analysis. One would expect that the quality of 
the echocardiographic images and image 
analysis is superior when performed by a 
scientist for research purposes, compared to 
examinations and analysis performed in a 
clinical setting by clinicians. The reported 
feasibility in our studies is indeed very high, 
and probably higher than could be expected in 
a clinical setting. Thus, we do not have data on 
the robustness of our methods, and trials in a 
clinical setting are needed to clarify this issue. 
Technological developments may reduce the 
impact of this limitation. Images may be 
transferred on-line with minimal time delay for 
interpretation in high volume centers. In 
addition, automatic algorithms for assessment 
of strain are developed (Automated Function 
Imaging (AFI), GE Vingmed, Horten, Norway) 
which reduce the time and skill needed for 
interpretation. Developments in scanner 
technology also have made acquisition of high 
quality images easier, and this development is 
likely to continue. One must also not forget 
that this limitation applies to all methods used 
to evaluate patients, and even biochemical and 
electrocardiographic data are in need of skilled 
interpretation.  
The use of different observers to perform 
analysis of different parameters is an important 
strength in our studies. Also, strict blinding 
procedures are necessary to avoid observer 
bias. In our studies, blinding was performed by 
applying random identification numbers 
generated by an independent investigator to 
each patient, and the code was broken only 
after all analyses were performed. The 
procedure was repeated for analysis of follow 
up tests. This ensures that no results were 
influenced by the results of other analysis. 
Choice and use of end points 
Use of hard end-points like death or recurrent 
MI would require a greatly increased study 
population and longer follow up than was 
available. For studies that rely on surrogate 
end-points, like ours, it is important that these 
are well defined and clinically meaningful.  
In study I, we used acute coronary occlusion as 
end-point, and patients were dichotomized 
accordingly. Acute coronary occlusion was 
defined as TIMI flow 0 or 1 in the IRA. The 
rationale behind using this as an end-point is 
two sided. Identification of patients with acute 
occlusion is important, because acute coronary 
occlusion is an independent predictor of poor 
prognosis.4 In addition, patients with acute 
coronary occlusion are logically the ones most 
likely to benefit from acute reperfusion 
therapy, as this may restore flow and salvage 
viable myocardium. 
The main problem using acute coronary 
occlusion as an endpoint is the diversity of the 
coronary anatomy. The same vessel will, in 
different patients, have differences in diameter 
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and length, and thus differences in the size of 
the perfusion territory. Interestingly though, 
infarct size was no different in patients with a 
proximal occlusion vs. distal occlusion or 
occlusion in a side branch (median 8.6% vs. 
median 8.3%, p=0.98, unpublished data). This 
may be because patients with proximal 
occlusions are more likely to develop ST 
segment elevations, and these patients were 
excluded from our study.  
In paper II, we used infarct size measured by 
CE-MRI as end point. The association between 
final infarct size and subsequent mortality and 
adverse events is well established,1,27,30-33 and 
infarct size is much used as a surrogate end 
point. Stratification based on early assessment 
of the predicted infarct size is also likely to 
facilitate tailored treatment algorithms for 
NSTEMI patients. CE-MRI is today 
considered the gold standard for estimation of 
final infarct size.34  The association between 
LV systolic function and infarct size is well 
established in chronic MI,35  and also shortly 
after reperfusion in STEMI patients.36 No 
study to date has attempted echocardiographic 
prediction of infarct size prior to reperfusion in 
NSTEMI patients. 
Infarct size can be assessed both on a linear 
scale and dichotomized at a given cut point. In 
study II, both methods were used. We present 
scatter plots and regression coefficients 
demonstrating a linear relationship between 
infarct size as percentage of LV myocardial 
volume and different echocardiographic 
estimates of LV systolic function. In order to 
estimate sensitivities and specificities of a 
method, it is necessary to dichotomize the 
study population. It is important that the 
chosen cut point has a clinical correlate. On 
small populations, cut points which fit the data 
set can be chosen that erroneously over 
estimate the discriminating ability of a method.  
We suggest infarct size ≥12% as cut point. 
This is primarily based on two previous 
studies, which demonstrate increased mortality 
in patients with infarct size ≥12%.
1,27 An 
infarct size of 12% may intuitively seem small. 
However, one large trial found 12% to be 
median infarct size in STEMI patients treated 
by acute reperfusion.27 More recently, mean 
final infarct size estimated with modern CE-
MRI methods was found to be 10% in patients 
with reperfused anterior STEMI (LAD as 
infarct related artery).37 One small study found 
infarct size measured by CE-MRI ≥18% to be 
associated with increased risk of adverse 
events,30 suggesting using a cut off set higher. 
However, it is intuitively reasonable to at least 
attempt to identify NSTEMI patients with 
infarct size larger than a typical STEMI 
patient, and a cut point set higher would in our 
opinion be too conservative. Still, applying 
18% as cut point on our material uniformly 
yields increasesed discriminating power of all 
parameters of LV systolic function, compared 
to a cut off at 12%. Even LVEF, the parameter 
that performs least well, achieves an AUC of 
0.89, compared to 0.80 using 18% as cut point. 
Thus, we chose to use 12% as cut off not 
because it by chance fitted our data, but since 
in our opinion it is the one that is the most 
clinically meaningful, and is associated with 
increased mortality. 
In studies III and IV, the end point was 
changes in global and regional LV systolic 
function, measured by longitudinal strain. In 
study III, we assessed viability, defined as the 
crude difference in systolic function prior to 
revascularization compared to follow up, 8±3 
months later. This definition is the one that 
carries immediate clinical and prognostic 
information for the individual patient. Today, 
contrast enhancement on MRI comprising less 
than 50% of a segment is often used 
synonymous to viability. It is important, 
however, to remember that CE-MRI only 
represents a surrogate measure of viability. 
Indeed, in the study validating CE-MRI as a 
measure of viability, the ability to improve 
contractile function after revascularization was 
used as reference method.26 In addition, the 
validation study was performed on patients 
with predominantly chronic CAD, and the 
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findings do not necessarily translate to the 
setting of acute MI. True viability corresponds 
to the ability to improve contractile function. 
Therefore, we feel this is the definition that 
should be used when such data are available.  
Assessment of viability was performed after 
adjustment for systolic function at baseline. 
This adjustment is very important, but often 
not applied in studies assessing potential 
markers of viability.38,39  Patients with a large 
impairment at baseline, will also have larger 
absolute potential of recovery. Thus, absolute 
recovery will be larger in patients with major 
impairment compared to minor, by statistical 
“regression to the mean”. The strong 
correlation between viability (∆Strain) and 
baseline systolic function confirms this 
confounding effect. Failure to adjust for 
systolic function at baseline may result in 
paradoxical findings, as factors may be 
identified as predictors of viability, simply 
through being associated with the level of 
baseline impairment. Indeed, PSS is associated 
with the level of baseline impairment, and is a 
significant predictor of viability in unadjusted 
analysis.  This does not necessarily imply that 
PSS has any clinical value in predicting 
viability. However, PSS remains significant 
after adjustment for baseline function, 
confirming it to be an independent predictor of 
viability, and therefore clinically valuable. In 
our study, several potential factors that may 
affect viability, including PSS, angiographic 
severity of the IRA and levels of TnT, were 
studied. After adjustment for baseline systolic 
function, we found PSS to be the strongest 
independent predictor of viability. This easily 
measured parameter may facilitate 
identification of patients who potentially will 
and those who will not benefit from 
revascularization.  
In study IV, we demonstrate changes in LV 
systolic function in patients with NSTEMI 
awaiting coronary angiography. As discussed 
below, strain echocardiography is an excellent 
tool for identification of small but significant 
changes in LV systolic function. Our findings 
are merely descriptive, and we have no data to 
describe what causes this deterioration. 
Potentially, changes may be caused by factors 
within the myocardium, as a result of ischemia, 
infarct expansion and development of edema. 
In addition, changes may be caused by 
alterations in blood supply to the myocardium. 
Indeed, atherothrombosis is a highly dynamic, 
process. Even with anticoagulation and triple 
platelet inhibition, there is a high incidence of 
recurrent ischemia and infarction in patients 
awaiting coronary angiography.40 Irrespective 
of the cause, the observed changes are 
important, as they persist at follow up. This 
provides a rationale for early intervention in 
patients with NSTEMI, to improve long term 
LV systolic function. 
The discriminating ability of ST segment 
deviations in the ECG was not a primary 
objective in our studies. Still, the ECG is the 
most widely used tool for risk stratification of 
patients with chest pain in the acute phase, and 
the association between ECG changes and 
acute coronary occlusion and infarct size are 
reported in paper I and II, respectively. 
Findings are consistently disappointing. 
Neither the sum of ST segment deviations nor 
prevalence of an ischemic ECG was increased 
in patients with acute coronary occlusion.  
Patients with ischemic changes in the 
presenting ECG had increased infarct size 
compared to patients with normal or non 
specific findings. However, ischemic ECG 
changes were found in only 7 out of 13 
patients (54%) with substantial infarction 
(infarct size ≥12%), and prevalence of 
ischemic ECG findings was not statistically 
different from patients with smaller infarcts. 
Therefore, in ACS patients without ST-
segment elevation, the ECG is not an accurate 
tool to stratify patients with respect to coronary 
pathology or extent of myocardial necrosis. An 
example is demonstrated in Figure 4. 
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Figure 4. Example of a patient with acute MI without ST-segment deviations. 
ECG is shown in panel A and B. Coronary angiography revealed thrombotic 
occlusion of a large intermediate branch. White arrow in panel C indicates 
site of occlusion, panel D shows the result after PCI with stent was 
performed. A bulls eye plot of strain values in panel E demonstrate impaired 
systolic function in the lateral wall. MRI images from the same patient are 
demonstrated in figure 2.  
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DETAILED DISCUSSION OF 
ECHOCARDIOGRAPHIC METHODS. 
Strain echocardiography and LVEF were used 
in all papers in this thesis. In papers I and II, 
we also used WMSI for quantification of LV 
systolic function. LVEF is the measure most 
widely used clinically. Guidelines on treatment 
of heart failure and prevention of sudden death 
consistently use LVEF to stratify patients.41-44 
The effect of a new treatment is often 
measured by its effect on LVEF.45-47 
Nevertheless, LVEF has several limitations. 
Agreement between observers and 
reproducibility is suboptimal.11 This is 
important, since inaccuracy in measurements 
introduces noise. From a research point of 
view, this necessitates increased sample sizes 
to demonstrate differences between groups or 
effects of treatment. Clinically, it reduces 
diagnostic accuracy. In our studies, the 
performance of LVEF was consistently inferior 
to that of strain echocardiography and WMSI 
for prediction of acute coronary occlusion and 
final infarct size. In study II, we found a 
relative reduction of 9 percentage points in 
LVEF in patients with infarct size ≥ 12% 
compared to patients with smaller infarcts. 
Nevertheless, the ability to identify individual 
patients was significantly inferior to strain. In 
study IV, a small but significant impairment of 
longitudinal systolic strain was demonstrated, 
while no significant difference was evident by 
LVEF. This may well be because LVEF is an 
inaccurate measure of LV systolic function, 
and a larger sample would be needed to 
demonstrate such a difference.  
Another drawback of LVEF is that is 
insensitive to smaller areas with impaired 
systolic function. Acute coronary occlusion 
and myocardial infarction predominantly cause 
regional impairment of LV systolic function. 
Increased contractions in remote areas may 
decrease the impact on LVEF, thereby 
concealing regional impairments.  
WMSI demonstrated discriminating ability 
similar to strain echocardiography in our 
papers I and II. WMSI is an established 
parameter of LV systolic function, validated as 
a prognostic indicator after MI, superior to 
LVEF.48 It is, however, semi quantitative, 
experience dependent and based on subjective 
interpretation of myocardial motion. Since all 
normal segments are scored 1, WMSI is not 
affected by increased contractions in remote 
myocardium, and is therefore more sensitive 
towards detection of small regions with 
impaired systolic function compared to LVEF.  
Calculation of an exact WMSI is quite rapidly 
obtained, does require use of simple 
mathematic calculation. Even more rapid is a 
rough count of the number of segments with 
decreased contractions. The experienced 
cardiologist can perform such an estimate 
within 1-2 minutes, based on three apical 
projections. In our study, only 30 out of 143 
segments with impaired contractions were 
akinetic or dyskinetic (WMS = 3 or 4). 
Therefore, we find a close association between 
WMSI and the number of segments with WMS 
larger or equal to 2 (r=0.96, p<0.001). The 
correlation between this “segment count” and 
infarct size is similar to WMSI (r=0.73, vs. 
r=0.74, both p<0.001). Visual assessment of 
how many segments demonstrating WMS 
larger or equal to 2 may represent the fastest 
method to estimate final infarct size. In stable 
patients, time consumption is not very 
important. However, if echocardiographic 
methods are to be used for risk stratification of 
patients with suspected ACS, a less time 
consuming method is likely to be applied more 
often. For identification of patients with infarct 
size ≥12%, a finding of 3 or more segments 
with WMS ≥2 yield a sensitivity of 100% and 
specificity of 71%.  
Strain echocardiography was used in all papers 
in this thesis, for quantification of LV 
deformation. Strain echocardiography 
represents an accurate validated measure of LV 
systolic function.16,17 It has been shown to be 
superior to visual assessment of wall motion in 
detection and quantification of regional 
systolic dysfunction.49 Recent developments 
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facilitate assessment of strain from 2D images 
(speckle tracking), which has reduced post 
processing, time consumption and has largely 
overcome the angel dependency limitation of 
Doppler strain.17 Global longitudinal strain by 
speckle tracking has been introduced and 
validated as a measure of LV systolic 
function,50 and has proven superior to LVEF 
and WMSI for prediction of all cause 
mortality.51 
One important feature of strain is that it is 
measured on a linear scale. This enables 
quantification of differences too small to be 
detected by the ordinal 4 level scale of WMS, 
especially when analyzed on a regional or 
segmental basis. Thus, sensitivity towards 
detection of small but clinically significant 
differences is increased. The small but 
significant decrease is systolic function 
between admittance and coronary angiography 
demonstrated in paper IV is an example of this.  
Importantly, strain echocardiography enables 
not only quantification of deformation, but also 
timing of such. This is important when 
assessing patients with dyssynchrony. 
Recently, regional differences in timing of 
contractions, “mechanical dispersion”, are 
demonstrated to be a predictor of malignant 
arrhythmias.52 In paper III, strain was used 
both to quantify systolic function, but also 
PSS. PSS occurs within the first 100-150 ms 
after aortic valve closure. When the aortic 
valve is not visualized, as is the case in apical 
four-chamber and two-chamber view, it is 
difficult visually to ascertain if myocardial 
deformation occurs within systole or in the 
early phase of diastole. This may lead to 
erroneous overestimation of segmental systolic 
function, if myocardial deformation occurs 
predominantly within diastole. This limitation 
of visual assessment is overcome by use of 
strain echocardiography.  
As opposed to LVEF, reproducibility is 
excellent for strain measured by speckle 
tracking. Intra class correlation coefficient for 
LV global strain for both inter and intra 
observer variability has previously been 
reported > 0.90,18 which is confirmed in our 
studies. As mentioned above, this is important 
both from a clinical and research point of view.   
Longitudinal vs. circumferential strain, 
radial strain and torsion 
Systolic myocardial deformation is complex, 
comprising shortening along longitudinal and 
circumferential axes, and as a consequence, 
thickening along a radial axis. In addition, LV 
torsion, a result of oppositely directed rotation 
of the apical and basal planes, has been 
introduced and validated as a measure of LV 
global systolic function.20 Doppler strain can 
only be measured parallel to the ultrasound 
beam, and is therefore only feasible in the 
longitudinal direction. Speckle tracking is 
feasible for measuring strain in all three 
directions, as well as assessment of LV 
rotation and torsion. When directly compared, 
longitudinal and circumferential strain by 
speckle tracking have previously demonstrated 
similar ability to predict final infarct size in 
patients with STEMI.35  
In study II, we used strain in all directions as 
well as LV torsion for early estimation of final 
infarct size. We found the performance of 
longitudinal strain to be superior compared to 
circumferential strain, radial strain and torsion.  
There are several possible reasons for this, 
both methodological and physiological. 
Methodologically, longitudinal strain has the 
advantage of tracking motion parallel to the 
ultrasound beam. Resolution in this direction is 
limited by wavelength, typically 0.5-1mm. 
Circumferential and radial strains are 
dependant of tracking motion in all directions 
compared to the ultrasound beam. Resolution 
perpendicular to the ultrasound beam is limited 
by line density. Echocardiographic ultrasound 
probes are non-linear, and lateral resolution is 
therefore also dependant on depth. Poor 
resolution leading to suboptimal tracking may 
therefore be one reason for the poor 
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performance of circumferential and radial 
strains.  
Another factor is that strain in the latter 
directions are based on short axis images, 
where the image planes are difficult to 
accurately define. In addition, there is 
considerable through plane motion, especially 
in the basal parts of the heart. Since the mitral 
annular plane moves 10-12mm in the apical 
direction during systole, different regions of 
the myocardium is assessed through one 
cardiac cycle. If the echocardiographic plane in 
end systole extends into the left atrium, severe 
differences in strain may occur. This may be 
the reason why some investigators have chosen 
to use only circumferential strain from the mid 
ventricular level to assess global LV systolic 
function.53  
CLINICAL PERSPECTIVE 
The main objective of this thesis was to 
develop methods to stratify patients with 
NSTE-ACS based on echocardiographic 
assessment of LV systolic function. The 
NSTE-ACS population is very heterogenous. 
Since the introduction of more sensitive 
biochemical markers of myocardial necrosis, 
an increasing number of patients with NSTE-
ACS are diagnosed with myocardial 
infarction.54 A majority of these patients have a 
patent IRA, develop small infarctions, and 
have a good prognosis. Therefore, emphasis 
must be applied to identification of the 
minority of patients with more serious disease. 
Our findings clearly demonstrate that 
echocardiography represent an accurate tool to 
identify patients with acute coronary occlusion 
or substantial MI. These patients comprise a 
significant proportion of the NSTE-ACS 
population, and may benefit from acute 
reperfusion therapy. 
Previous studies have found that acute 
revascularization of patients with NSTEMI is 
not associated with any harm,
55
 and a clear 
benefit in patients at high risk.40,55 Immediate 
revascularization is unlikely to be feasible in 
all patients with NSTE-ACS, due to the large 
volume of patients, and difficulty in providing 
an exact early diagnosis in patients with chest 
pain. Therefore, stratification is important in 
order to identify patients at high risk. 
The rationale for acute reperfusion therapy in 
NSTEMI patients is similar to that in STEMI 
patients; myocardial salvage and reduction of 
final infarct size. Whether this can be achieved 
in the NSTEMI population has never been 
unequivocally demonstrated. Reduction in 
infarct size by acute angioplasty was the 
primary end point of the “Acute Balloon 
Angioplasty vs. Traditional Early Invasive 
Treatment of Non-ST-Elevation Myocardial 
Infarction” (DaNSTEMI2) trial 
(ClinicalTrials.gov Id: NCT00493584). 
Unfortunately, this trial was terminated 
prematurely due to insufficient patient 
inclusion. Nevertheless, there is little reason to 
believe that acute reperfusion would not be 
beneficial in a patient with acute coronary 
occlusion and substantial MI, with or without 
ST segment elevation.  
This thesis was named “Echocardiographic 
Stratification of Acute Coronary Syndrome” 
(Echo-Str-ACS). Str-ACS phonetically 
resembles the Norwegian word “straks”, which 
translates into “immediately”, reflecting our 
view on when echocardiography could with 
benefit be performed on patients with 
suspected ACS.   
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Conclusions 
General conclusion: 
Our studies confirm that echocardiography is a valuable tool for risk stratification and evaluation of 
patients with NSTE-ACS. Patients with acute coronary occlusion or substantial MI can be accurately 
identified by echocardiography, providing means to identify patients who may benefit from urgent 
reperfusion therapy. PSS estimated by strain echocardiography prior to revascularization is an 
independent predictor of viability. Strain echocardiography also demonstrates a progressive 
impairment of LV systolic function in patients awaiting coronary angiography.  
 
Specific conclusions: 
I. LVEF, WMSI and global are impaired in patients with acute coronary occlusion, while risk 
area measured by strain or WMS is increased in patients with acute coronary occlusion, 
compared to patients with a patent IRA. Strain echocardiography and WMS are superior to 
LVEF for identification of individual patients with acute coronary occlusion.  
 
II. There is a significant linear relationship between final infarct size assessed by CE-MRI and 
global longitudinal-, radial- and circumferential strain, LVEF and WMSI. For identification of 
individual patients with substantial MI (≥12%), WMSI and global longitudinal strain has 
excellent discriminating power, superior to LVEF, torsion, radial- and circumferential strain.  
 
III. In patients with NSTEMI, PSS assessed by strain echocardiography prior to revascularization 
is a strong independent predictor of viability in patients who undergo successful 
revascularization. The predictive power is superior to biochemical estimates of myocardial 
necrosis and angiographic severity of the IRA.  
 
IV. During the first 24 hours after admittance for NSTE-ACS, there is a progressive impairment of 
LV systolic function assessed by longitudinal systolic strain. This impairment is most 
pronounced in patients with an occluded IRA at time of angiography, and also most 
pronounced in the myocardial region supplied by the IRA.  
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